Broughton CEO, Chris Allen, has written a letter to the Editor of The Grocer in response to a recent article they published about underage vaping.
Nicotine
Analytical Testing
Promoting a Smoke Free Future Through Scientific Testing and Analysis
Helping you bring reduced risk products, including e-cigarettes, heated tobacco products, and modern oral nicotine pouches, to market to drive tobacco harm reduction. Our experienced scientists will help build the evidence needed to satisfy regulators’ expectations of reduced risk.
We also have extensive experience generating evidence to support nicotine replacement therapies such as pouches and gums.
Analytical Method Development and Validation
QC Release Testing
Stability Storage and Analysis
Harmful and Potentially Harmful Constituents (HPHC)
Toxicology Testing for NGP
Extractables and Leachables
Product Assessment
Arrange a meeting with a scientific expert with years of experience in the nicotine sector to discuss your project and learn how we can help optimize your success and reduce risk.
Nicotine Testing Services Resources
Learn more about how we can help bring your nicotine delivery product to market through our high-quality analytical testing services.
Whitepaper: Nicotine Pouches: An Extraordinary Opportunity to support Tobacco Harm Reduction
There is no doubt that the reduced-risk industry today is at an impasse, although there is now common acceptance that combustible cigarettes are the most hazardous form of nicotine delivery due to the accompanying harmful chemicals produced from tobacco combustion.
Next Generation Nicotine Products Service Guide
We help companies of all sizes through the product lifecycle stages, from concept innovation, product realization, and regulatory submission to post marketing surveillance.
PMTA Guide For NGP businesses
At Broughton, our consultants have deep industry knowledge across all the elements required for a PMTA. We guide you through and generate the required data, to ensure that FDA finds your applications strong and compelling.
Strategic Insights to reignite PMTA confidence
Dr. Nveed Chaudhary Chief Scientific and Regulatory Officer, Paul Hardman Managing Consultant Chemistry and Manufacturing Controls, and, Libby Clarke Managing Consultant Toxicology share their thoughts on how to reduce costs and protect timelines while continuing to innovate.
With the recent updates from Health Canada (HC) regarding reporting requirements for vaping products, concern has been raised from the industry about ....
Throughout 2023 many column inches have been devoted to scrutiny of vapes.
Arrange a meeting with a scientific or regulatory expert to discuss your project and learn how we can help to maximize your success.
